104 related articles for article (PubMed ID: 38650948)
21. Evaluation of the Efficacy of OSU-2S in the Treatment of Non-Small-Cell Lung Cancer and Screening of Potential Targets of Action.
Han M; Liu X; Hailati S; Nurahmat N; Dilimulati D; Baishan A; Aikebaier A; Zhou W
Pharmaceuticals (Basel); 2024 May; 17(5):. PubMed ID: 38794152
[TBL] [Abstract][Full Text] [Related]
22. Quantitative Proteomic Analysis Reveals Functional Alterations of the Peripheral Immune System in Colorectal Cancer.
Zhu W; Li M; Wang Q; Shen J; Ji J
Mol Cell Proteomics; 2024 May; 23(6):100784. PubMed ID: 38735538
[TBL] [Abstract][Full Text] [Related]
23. Ultrasound-induced immune responses in tumors: A systematic review and meta-analysis.
Rix A; Heinrichs H; Porte C; Leenaars C; Bleich A; Kiessling F
J Control Release; 2024 May; 371():146-157. PubMed ID: 38777126
[TBL] [Abstract][Full Text] [Related]
24. Immune modulations during chemoimmunotherapy & novel vaccine strategies--in metastatic melanoma and non small-cell lung cancer.
Iversen TZ
Dan Med J; 2013 Dec; 60(12):B4774. PubMed ID: 24355457
[TBL] [Abstract][Full Text] [Related]
25. Dendritic Cell Vaccination in Non-Small Cell Lung Cancer: Remodeling the Tumor Immune Microenvironment.
Abascal J; Oh MS; Liclican EL; Dubinett SM; Salehi-Rad R; Liu B
Cells; 2023 Oct; 12(19):. PubMed ID: 37830618
[TBL] [Abstract][Full Text] [Related]
26. Short-chain fatty acids induced lung tumor cell death and increased peripheral blood CD4+ T cells in NSCLC and control patients ex vivo.
Thome CD; Tausche P; Hohenberger K; Yang Z; Krammer S; Trufa DI; Sirbu H; Schmidt J; Finotto S
Front Immunol; 2024; 15():1328263. PubMed ID: 38650948
[TBL] [Abstract][Full Text] [Related]
27. Effects of IFN-γ on the immunological microenvironment and TAM polarity in stage IA non-small cell lung cancer and its mechanisms.
Zhao W; Wang H; Zhang X; Zhang L; Pu W; Ma Y; Chen W
BMC Pulm Med; 2024 Jan; 24(1):46. PubMed ID: 38254043
[TBL] [Abstract][Full Text] [Related]
28. Clinical significance of PD-L1-positive cancer-associated fibroblasts in pN0M0 non-small cell lung cancer.
Teramoto K; Igarashi T; Kataoka Y; Ishida M; Hanaoka J; Sumimoto H; Daigo Y
Lung Cancer; 2019 Nov; 137():56-63. PubMed ID: 31546072
[TBL] [Abstract][Full Text] [Related]
29. Lung cancer is associated with decreased expression of perforin, granzyme B and interferon (IFN)-γ by infiltrating lung tissue T cells, natural killer (NK) T-like and NK cells.
Hodge G; Barnawi J; Jurisevic C; Moffat D; Holmes M; Reynolds PN; Jersmann H; Hodge S
Clin Exp Immunol; 2014 Oct; 178(1):79-85. PubMed ID: 24894428
[TBL] [Abstract][Full Text] [Related]
30. Total flavonoids of Taraxacum mongolicum inhibit non-small cell lung cancer by regulating immune function.
Kang L; Miao MS; Song YG; Fang XY; Zhang J; Zhang YN; Miao JX
J Ethnopharmacol; 2021 Dec; 281():114514. PubMed ID: 34384846
[TBL] [Abstract][Full Text] [Related]
31. Functional Heterogeneity of CD4
Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P
Front Immunol; 2018; 9():2654. PubMed ID: 30505306
[TBL] [Abstract][Full Text] [Related]
32. Short-chain fatty acids in cancer pathogenesis.
Feitelson MA; Arzumanyan A; Medhat A; Spector I
Cancer Metastasis Rev; 2023 Sep; 42(3):677-698. PubMed ID: 37432606
[TBL] [Abstract][Full Text] [Related]
33. Cancer statistics, 2023.
Siegel RL; Miller KD; Wagle NS; Jemal A
CA Cancer J Clin; 2023 Jan; 73(1):17-48. PubMed ID: 36633525
[TBL] [Abstract][Full Text] [Related]
34. Sodium butyrate in both prevention and supportive treatment of colorectal cancer.
Kaźmierczak-Siedlecka K; Marano L; Merola E; Roviello F; Połom K
Front Cell Infect Microbiol; 2022; 12():1023806. PubMed ID: 36389140
[TBL] [Abstract][Full Text] [Related]
35. Butyrate Inhibits Gastric Cancer Cells by Inducing Mitochondriamediated Apoptosis.
Zhang K; Ji X; Song Z; Wu F; Qu Y; Jin X; Xue X; Wang F; Huang Y
Comb Chem High Throughput Screen; 2023; 26(3):630-638. PubMed ID: 35864794
[TBL] [Abstract][Full Text] [Related]
36. Glucose-Restricted Diet Regulates the Tumor Immune Microenvironment and Prevents Tumor Growth in Lung Adenocarcinoma.
Gähler A; Trufa DI; Chiriac MT; Tausche P; Hohenberger K; Brunst AK; Rauh M; Geppert CI; Rieker RJ; Krammer S; Leberle A; Neurath MF; Sirbu H; Hartmann A; Finotto S
Front Oncol; 2022; 12():873293. PubMed ID: 35574343
[TBL] [Abstract][Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
